These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

70 related items for PubMed ID: 3639908

  • 1. In vitro generation of an HTLV-III variant by neutralizing antibody.
    Robert-Guroff M, Reitz MS, Robey WG, Gallo RC.
    J Immunol; 1986 Nov 15; 137(10):3306-9. PubMed ID: 3639908
    [Abstract] [Full Text] [Related]

  • 2. HTLV-III neutralizing antibody development in transfusion-dependent seropositive patients with beta-thalassemia.
    Robert-Guroff M, Giardina PJ, Robey WG, Jennings AM, Naugle CJ, Akbar AN, Grady RW, Hilgartner MW.
    J Immunol; 1987 Jun 01; 138(11):3731-6. PubMed ID: 3495568
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Construction of an HIV-1 peptide vaccine containing a multideterminant helper peptide linked to a V3 loop peptide 18 inducing strong neutralizing antibody responses in mice of multiple MHC haplotypes after two immunizations.
    Ahlers JD, Pendleton CD, Dunlop N, Minassian A, Nara PL, Berzofsky JA.
    J Immunol; 1993 Jun 15; 150(12):5647-65. PubMed ID: 8515081
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. DNA vaccines expressing glycoprotein complex II antigens gM and gN elicited neutralizing antibodies against multiple human cytomegalovirus (HCMV) isolates.
    Shen S, Wang S, Britt WJ, Lu S.
    Vaccine; 2007 Apr 30; 25(17):3319-27. PubMed ID: 17287056
    [Abstract] [Full Text] [Related]

  • 14. Designed recombinant adenovirus type 5 vector induced envelope-specific CD8(+) cytotoxic T lymphocytes and cross-reactive neutralizing antibodies against human immunodeficiency virus type 1.
    Ura T, Yoshida A, Xin KQ, Yoshizaki S, Yashima S, Abe S, Mizuguchi H, Okuda K.
    J Gene Med; 2009 Feb 30; 11(2):139-49. PubMed ID: 19065543
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Japanese encephalitis protein vaccine candidates expressing neutralizing epitope and M.T hsp70 induce virus-specific memory B cells and long-lasting antibodies in swine.
    Fei-fei G, Jian W, Feng X, Li-ping S, Quan-yun S, Jin-ping Z, Pu-yan C, Pei-hong L.
    Vaccine; 2008 Oct 16; 26(44):5590-4. PubMed ID: 18761388
    [Abstract] [Full Text] [Related]

  • 19. Neutralizing antibodies and the course of HIV-induced disease.
    Wendler I, Bienzle U, Hunsmann G.
    AIDS Res Hum Retroviruses; 1987 Oct 16; 3(2):157-63. PubMed ID: 3650100
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.